Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10353 in Chinese Adults With Depression
NCT05938179Phase 2Unknown
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Aug 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of HS-10353 in major depressive disorder (MDD), sponsored by Hansoh Pharmaceutical Group. Status: unknown.
02
Drugs
HS-10353
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05938179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05938179.